NO20044104L - Ikke-nukleoside reverstranskriptase-inhibitorer - Google Patents

Ikke-nukleoside reverstranskriptase-inhibitorer

Info

Publication number
NO20044104L
NO20044104L NO20044104A NO20044104A NO20044104L NO 20044104 L NO20044104 L NO 20044104L NO 20044104 A NO20044104 A NO 20044104A NO 20044104 A NO20044104 A NO 20044104A NO 20044104 L NO20044104 L NO 20044104L
Authority
NO
Norway
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
nucleoside
inhibitors
Prior art date
Application number
NO20044104A
Other languages
English (en)
Norwegian (no)
Inventor
Christiane Yoakim
Bounkham Thavonekham
Jeffrey O'meara
Julie Naud
Bruo Simoneau
Eric Malenfant
Serge R Landry
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20044104L publication Critical patent/NO20044104L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20044104A 2002-05-16 2004-09-27 Ikke-nukleoside reverstranskriptase-inhibitorer NO20044104L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38088602P 2002-05-16 2002-05-16
PCT/CA2003/000718 WO2003097644A2 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
NO20044104L true NO20044104L (no) 2004-12-01

Family

ID=29550032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044104A NO20044104L (no) 2002-05-16 2004-09-27 Ikke-nukleoside reverstranskriptase-inhibitorer

Country Status (28)

Country Link
US (1) US6806265B2 (sr)
EP (1) EP1506195B1 (sr)
JP (1) JP4230448B2 (sr)
KR (1) KR20050008716A (sr)
CN (1) CN1318421C (sr)
AR (1) AR040027A1 (sr)
AT (1) ATE412653T1 (sr)
AU (1) AU2003229186A1 (sr)
BR (1) BR0310033A (sr)
CA (1) CA2485916C (sr)
DE (1) DE60324418D1 (sr)
EA (1) EA009178B1 (sr)
EC (1) ECSP045432A (sr)
ES (1) ES2315492T3 (sr)
HR (1) HRP20041065A2 (sr)
IL (1) IL163753A0 (sr)
MX (1) MXPA04010409A (sr)
MY (1) MY134646A (sr)
NO (1) NO20044104L (sr)
NZ (1) NZ536736A (sr)
PE (1) PE20040365A1 (sr)
PL (1) PL371663A1 (sr)
RS (1) RS98004A (sr)
TW (1) TW200404071A (sr)
UA (1) UA79285C2 (sr)
UY (1) UY27809A1 (sr)
WO (1) WO2003097644A2 (sr)
ZA (1) ZA200406912B (sr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
WO2004087169A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of nevirapine and a further antiretroviral compound
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
CA2532403A1 (en) * 2003-07-17 2005-02-03 James Arnold Ppar active compounds
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
DE102004051277A1 (de) * 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
JP2008521829A (ja) * 2004-11-30 2008-06-26 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
JP2009509932A (ja) * 2005-09-07 2009-03-12 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
WO2007030559A2 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. 1, 3-disubstituted indole derivatives for use as ppar modulators
BRPI0615948A2 (pt) * 2005-09-07 2011-05-31 Plexxikon Inc composto ativo de ppar, sua composição, seu kit e seu uso
US8492428B2 (en) 2005-09-20 2013-07-23 Mayo Foundation For Medical Education And Research Small-molecule botulinum toxin inhibitors
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
CN107428747A (zh) 2014-11-25 2017-12-01 拜耳制药股份公司 取代的吡啶并苯并二氮杂*酮衍生物及其用途
ES2946917T3 (es) 2017-07-21 2023-07-27 Antabio Sas Compuestos químicos
BR112020018094A2 (pt) 2018-03-08 2020-12-22 Incyte Corporation Compostos de aminopirazina diol como inibidores de pi3k-¿
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
CN118103038A (zh) * 2021-08-20 2024-05-28 英安塔制药有限公司 17β-羟基类固醇脱氢酶13型抑制剂及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TWI270547B (en) 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
CA2485916C (en) 2009-12-08
CN1653066A (zh) 2005-08-10
IL163753A0 (en) 2005-12-18
MXPA04010409A (es) 2005-02-17
DE60324418D1 (de) 2008-12-11
UY27809A1 (es) 2003-12-31
NZ536736A (en) 2006-11-30
TW200404071A (en) 2004-03-16
UA79285C2 (en) 2007-06-11
HRP20041065A2 (en) 2005-04-30
ATE412653T1 (de) 2008-11-15
MY134646A (en) 2007-12-31
JP4230448B2 (ja) 2009-02-25
ES2315492T3 (es) 2009-04-01
EA200401482A1 (ru) 2005-06-30
HK1080849A1 (en) 2006-05-04
EP1506195B1 (en) 2008-10-29
EP1506195A2 (en) 2005-02-16
BR0310033A (pt) 2005-02-15
US6806265B2 (en) 2004-10-19
CA2485916A1 (en) 2003-11-27
WO2003097644A2 (en) 2003-11-27
PL371663A1 (en) 2005-06-27
AU2003229186A1 (en) 2003-12-02
KR20050008716A (ko) 2005-01-21
PE20040365A1 (es) 2004-07-22
ECSP045432A (es) 2005-01-03
RS98004A (sr) 2006-12-15
AR040027A1 (es) 2005-03-09
CN1318421C (zh) 2007-05-30
WO2003097644A3 (en) 2004-02-05
EA009178B1 (ru) 2007-12-28
US20040006071A1 (en) 2004-01-08
JP2005526851A (ja) 2005-09-08
ZA200406912B (en) 2006-06-28

Similar Documents

Publication Publication Date Title
DE602004008227D1 (de) Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase
NO20161397A1 (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer
ATE505471T1 (de) Azaindol-kinaseinhibitoren
NO20053356D0 (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
DE602004018837D1 (de) Ptidase-iv-inhibitoren
NO20044104L (no) Ikke-nukleoside reverstranskriptase-inhibitorer
AU2003269628A1 (en) Non-nucleoside reverse transcriptase inhibitors
DE60118560D1 (de) Nicht-nukleosid reverse transkriptase inhibitoren
NO20044269L (no) Smamolekylaere inntrengningsinhibitorer
DK1499622T3 (da) Meterotricyclyl-6-alkylidenpenemer som beta-lactamaseinhibitorer
IL157543A0 (en) Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
ATE373648T1 (de) Nf-kappab-inhibitoren
NO20043610L (no) Fenylpyrimidinaminer som IgE inhibitorer
DE60307471D1 (de) Hemmung
DE50310384D1 (de) Strömungsmaschine
NO20044043L (no) Dipyridodiazepioner som revers-transkriptase-inhibitorer
DK1373267T3 (da) Non-nucleoside revers transkriptase-inhibitorer
UA7574S (uk) Експандер
ES1052497Y (es) Estuche para peonzas
NO20022152D0 (no) Kjöleskap for baderom
ITRE20020018A0 (it) Denocciolatrice
UA7721S (uk) Лінійка ортопедична